Jurnal Respirologi Indonesia10.36497/jri.v42i1.278202242119-27Analysis of Comorbidity and Its Association with Disease Severity and Mortality Rate in Hospitalized COVID-19 PatientsAnthony Christanto, Aditya Sri Listyoko, Ngakan Putu Parsama Putra,
10.21203/ of comorbidity burden on mortality in patients with COVID-19: a retrospective analysis of the Korean health insurance databaseSoo Ick Cho, Susie Yoon, Ho-Jin Lee,
European Journal of Medical and Health Sciences10.24018/ejmed.2021.3.6.113120213678-81Vitamin D Levels among Hospitalized and Non-Hospitalized COVID-19 Patients in Dr. M. Djamil General Hospital PadangHarika Putra, Efrida, Rismawati Yaswir,
Jurnal PROMKES10.20473/jpk.v9.i2.2021.168-176202192168Analysis of COVID-19 Prevention Behaviour among Diabetes Mellitus Comorbidity Patients in PalembangGiszka Putri, Hamzah Hasyim, Nur Alam Fajar,
Frontiers in Medicine10.3389/fmed.2022.85053620229Age, Sex, and Race/Ethnicity in Clinical Outcomes Among Patients Hospitalized With COVID-19, 2020Jusung Lee
Scientific Reports10.1038/s41598-021-85813-22021111Impact of comorbidity burden on mortality in patients with COVID-19 using the Korean health insurance databaseSoo Ick Cho, Susie Yoon, Ho-Jin Lee,,
Open Forum Infectious Diseases10.1093/ofid/ofab466.64020218Supplement_1S322-S323441. The Effects of Race and Comorbidity Burden on Inflammatory Biomarkers Among Persons Hospitalized with COVID-19Yetunde A Fatade, Lauren F Collins, Lauren F Collins, Zakaria Almuwaqqat, ZhenChao Chen, Mahadev Prasad, Arshed Quyyumi, Igho Ofotokun,
Infection & Chemotherapy10.3947/ic.2020.01492021532300Association of Early Favipiravir Use with Reduced COVID-19 Fatality among Hospitalized PatientsErcan Karatas, Lacin Aksoy, Ersin Ozaslan,,
European Heart Journal10.1093/eurheartj/ehaa935202041464389-4390The widely promoted antimalarial drug hydroxychloroquine confers no mortality benefit in hospitalized patients with COVID-19: comment on the ‘Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19’Giovanna Liuzzo, Carlo Patrono,